biotech

Merck Ups Stake in Schering, Threatening Bayer's Takeover

Filed in archive Corporate and Industrial News on June 13, 2006

Merck Ups Stake in Schering, Threatening Bayer's Takeover
It seems that the $20 billion merger between German biopharmaceutical giants Bayer and Schering may not take place afterall. Read the news from Forbes, from Reuters and from AP (via Canada.com): Merck KGaA has raised its holding by acquiring Schering stocks, thus threatening Bayer's takeover, which needs 75 percent of the shares for the deal to go through.
"It is highly likely the deal now is not going to go through," said Merck Finck & Co. analyst Carsten Kunold, who has a "hold" rating on Bayer.

For an oveview, be sure to read In the Pipeline's take.

Permalink: Merck Ups Stake in Schering, Threatening Bayer's Takeover

Tags: stocks  acquisition  biotech  bayer  merck  bayer+takeover  threatening+bayer  merck+stake 

Vote for Merck Ups Stake in Schering, Threatening Bayer's Takeover:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells